Literature DB >> 22975361

Comparison of FDG whole-body PET/CT and gadolinium-enhanced whole-body MRI for distant malignancies in patients with malignant tumors: a meta-analysis.

G Z Xu1, C Y Li, L Zhao, Z Y He.   

Abstract

BACKGROUND: We performed a meta-analysis to compare the performance of whole-body positron emission tomography/computed tomography (WB-PET/CT) with that of whole-body magnetic resonance imaging (WB-MRI) for the overall assessment of distant malignancies in patients with malignant tumors.
METHODS: We performed a meta-analysis of 13 available articles (1239 patients). We calculated sensitivities, specificities, positive likelihood ratios, and negative likelihood ratios, and constructed summary receiver operating characteristic curves using bivariate regression models for WB-PET/CT and WB-MRI, respectively.
RESULTS: Across nine studies (1070 patients), WB-PET/CT have similar patient-based sensitivity (0.85 versus 0.85) and specificity (0.96 versus 0.97) with WB-MRI. Across 5 studies (210 patients), WB-PET/CT have similar lesion-based sensitivity (0.85 vs 0.88) and specificity (0.90 vs 0.89) with WB-MRI. Across four studies (511 patients), the combined use may have higher patient-based sensitivity (0.89) than WB-PET/CT (0.82) and WB-MRI (0.81) alone.
CONCLUSION: Both WB-PET/CT and WB-MRI have good diagnostic performance for the overall assessment of distant malignancies in patients with malignant tumors. The combined use may provide more added value than WB-PET/CT and WB-MRI alone.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22975361     DOI: 10.1093/annonc/mds234

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  11 in total

1.  Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies.

Authors:  Stuart A Taylor; Susan Mallett; Anne Miles; Stephen Morris; Laura Quinn; Caroline S Clarke; Sandy Beare; John Bridgewater; Vicky Goh; Sam Janes; Dow-Mu Koh; Alison Morton; Neal Navani; Alfred Oliver; Anwar Padhani; Shonit Punwani; Andrea Rockall; Steve Halligan
Journal:  Health Technol Assess       Date:  2019-12       Impact factor: 4.014

2.  Whole-body magnetic resonance imaging (WB-MRI) in oncology: an Italian survey.

Authors:  Domenico Albano; Alessandro Stecco; Giuseppe Micci; Luca Maria Sconfienza; Stefano Colagrande; Alfonso Reginelli; Roberto Grassi; Alessandro Carriero; Massimo Midiri; Roberto Lagalla; Massimo Galia
Journal:  Radiol Med       Date:  2020-06-22       Impact factor: 3.469

Review 3.  Trends in Management of Oligometastatic Hormone-Sensitive Prostate Cancer.

Authors:  Gargi Kothari; Piet Ost; Patrick Cheung; Pierre Blanchard; Alison C Tree; Nicholas J van As; Simon S Lo; Drew Moghanaki; Andrew Loblaw; Shankar Siva
Journal:  Curr Oncol Rep       Date:  2019-03-27       Impact factor: 5.075

Review 4.  Cerebral Gluconeogenesis and Diseases.

Authors:  James Yip; Xiaokun Geng; Jiamei Shen; Yuchuan Ding
Journal:  Front Pharmacol       Date:  2017-01-04       Impact factor: 5.810

5.  Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L).

Authors:  Stuart A Taylor; Sue Mallett; Anne Miles; Sandy Beare; Gauraang Bhatnagar; John Bridgewater; Rob Glynne-Jones; Vicky Goh; Ashley M Groves; Sam M Janes; Dow Mu Koh; Steve Morris; Alison Morton; Neal Navani; Alf Oliver; Anwar R Padhani; Shonit Punwani; Andrea G Rockall; Steve Halligan
Journal:  BMC Cancer       Date:  2017-05-02       Impact factor: 4.430

6.  Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial.

Authors:  Stuart A Taylor; Sue Mallett; Sandy Beare; Gauraang Bhatnagar; Dominic Blunt; Peter Boavida; John Bridgewater; Caroline S Clarke; Marian Duggan; Steve Ellis; Robert Glynne-Jones; Vicky Goh; Ashley M Groves; Ayshea Hameeduddin; Sam M Janes; Edward W Johnston; Dow-Mu Koh; Anne Miles; Stephen Morris; Alison Morton; Neal Navani; John O'Donohue; Alfred Oliver; Anwar R Padhani; Helen Pardoe; Uday Patel; Shonit Punwani; Laura Quinn; Hameed Rafiee; Krystyna Reczko; Andrea G Rockall; Khawaja Shahabuddin; Harbir S Sidhu; Jonathan Teague; Mohamed A Thaha; Matthew Train; Katherine van Ree; Sanjaya Wijeyekoon; Steve Halligan
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-05-09

7.  Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial.

Authors:  Stuart A Taylor; Sue Mallett; Simon Ball; Sandy Beare; Gauraang Bhatnagar; Angshu Bhowmik; Peter Boavida; John Bridgewater; Caroline S Clarke; Marian Duggan; Steve Ellis; Robert Glynne-Jones; Vicky Goh; Ashley M Groves; Ayshea Hameeduddin; Sam M Janes; Edward W Johnston; Dow-Mu Koh; Sara Lock; Anne Miles; Stephen Morris; Alison Morton; Neal Navani; Alfred Oliver; Terry O'Shaughnessy; Anwar R Padhani; David Prezzi; Shonit Punwani; Laura Quinn; Hameed Rafiee; Krystyna Reczko; Andrea G Rockall; Peter Russell; Harbir S Sidhu; Nicola Strickland; Kathryn Tarver; Jonathan Teague; Steve Halligan
Journal:  Lancet Respir Med       Date:  2019-05-09       Impact factor: 30.700

8.  Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer.

Authors:  Ryo Kurashina; Toshiki Kijima; Akihito Okazaki; Hirotaka Fuchizawa; Issei Suzuki; Kazumasa Sakamoto; Hironori Betsunoh; Yoshitatsu Fukabori; Masahiro Yashi; Takao Kamai
Journal:  IJU Case Rep       Date:  2020-11-29

Review 9.  Whole body MRI: improved lesion detection and characterization with diffusion weighted techniques.

Authors:  Rajpaul Attariwala; Wayne Picker
Journal:  J Magn Reson Imaging       Date:  2013-08       Impact factor: 4.813

Review 10.  Evidence-based medicine and clinical fluorodeoxyglucose PET/MRI in oncology.

Authors:  Kenneth Miles; Liam McQueen; Stanley Ngai; Phillip Law
Journal:  Cancer Imaging       Date:  2015-11-17       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.